The vaccine Qdenga® reduces the risk of a severe dengue infection. This vaccine may be administered to children from the age of 4 years. It is a live attenuated vaccine and therefore should not be used in certain immune disorders, during pregnancy or breastfeeding.
Dengvaxia® is not available in Belgium and is not recommended for travellers.
When is vaccination recommended?
Travellers who have already had dengue at least six months earlier and
- are staying in a high-risk area for a long time (> 4 weeks) or travelling frequently through a high-risk area for dengue
- can receive two doses before departure
Vaccination schedule Qdenga®
- The schedule consists of two doses at a 3-month interval.
- The duration of protection has not yet been determined.